Company Filing History:
Years Active: 2019
Title: **Marlène Vuillemin: Innovator in Protein Synthesis**
Introduction
Marlène Vuillemin, based in Ramonville-Saint-Agne, France, is a prominent inventor in the field of biochemistry. With two significant patents attributed to his name, Vuillemin has made notable contributions to the understanding and utilization of dextrans and proteins with specific enzymatic activities.
Latest Patents
Vuillemin's latest patents focus on groundbreaking innovations involving proteins with dextran-saccharase activity. The first patent outlines a protein characterized by its dextran-saccharase activity, detailing amino acid sequences identified as SEQ ID NO: 1 and SEQ ID NO: 2. This invention also introduces a complex made up of a substrate and the aforementioned protein. Furthermore, Vuillemin has developed methods for synthesizing dextrans, gluco-oligosaccharides, and gluco-conjugates, alongside the resulting products from these processes.
His second patent addresses very high molar mass dextrans, which contain between 95% and 99% of α-1,6 glucosidic bonds. These dextrans possess a weight-average molar mass of at least 0.7 × 10^g.mol and a dispersity index D ranging from 1.3 to 3. The associated invention includes a dextran saccharase that enables the production of these specialized dextrans and the methods required for their synthesis.
Career Highlights
Vuillemin has significantly contributed to scientific research while working at reputable institutions such as the National Institute for Applied Sciences in Toulouse and the National Institute for Agronomic Research. His work in these establishments has allowed him to advance his research in the field of protein synthesis and dextran utilization.
Collaborations
Throughout his career, Marlène Vuillemin has collaborated with esteemed colleagues, including Marion Claverie and Claire Moulis. These partnerships have fostered a productive research environment and led to various innovations in biochemistry.
Conclusion
Marlène Vuillemin’s work as an inventor illustrates the impact of innovative research in the realm of protein synthesis and dextran development. With two patents to his name that focus on specific enzymatic activities and synthesis methods, Vuillemin continues to contribute significantly to the scientific community and advancements in biochemistry. His collaborations and career highlights reflect a commitment to excellence and innovation in the field.